Cargando…
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region
BACKGROUND: Weak governance over public sector pharmaceutical policy and practice limits access to essential medicines, inflates pharmaceutical prices, and wastes scarce health system resources. Pharmaceutical systems are technically complex and involve extensive interactions between the private and...
Autores principales: | Grundy, Quinn, Parker, Lisa, Wong, Anna, Fusire, Terence, Dimancesco, Deirdre, Tisocki, Klara, Walkowiak, Helena, Vian, Taryn, Kohler, Jillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931570/ https://www.ncbi.nlm.nih.gov/pubmed/35303902 http://dx.doi.org/10.1186/s12992-022-00822-8 |
Ejemplares similares
-
Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance
por: Vian, Taryn, et al.
Publicado: (2017) -
Increasing transparency and accountability in national pharmaceutical systems
por: Paschke, Anne, et al.
Publicado: (2018) -
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Kohler, Jillian Clare, et al.
Publicado: (2020) -
Conflict of Interest Disclosures
Publicado: (2017) -
Conflict of Interest Disclosures
Publicado: (2018)